Cleared Traditional

K220290 - Revitalair 430+ (FDA 510(k) Clearance)

May 2023
Decision
457d
Days
Class 2
Risk

K220290 is an FDA 510(k) clearance for the Revitalair 430+. This device is classified as a Chamber, Hyperbaric (Class II - Special Controls, product code CBF).

Submitted by Us Hyperbaric Network (Medley, US). The FDA issued a Cleared decision on May 4, 2023, 457 days after receiving the submission on February 1, 2022.

This device falls under the Anesthesiology FDA review panel. Regulated under 21 CFR 868.5470.

Submission Details

510(k) Number K220290 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 01, 2022
Decision Date May 04, 2023
Days to Decision 457 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF

Device Classification

Product Code CBF - Chamber, Hyperbaric
Device Class Class II - Special Controls
CFR Regulation 21 CFR 868.5470